Sei Investments Co. Purchases 88,468 Shares of FIGS, Inc. $FIGS

Sei Investments Co. raised its position in FIGS, Inc. (NYSE:FIGS) by 148.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 148,262 shares of the company’s stock after purchasing an additional 88,468 shares during the quarter. Sei Investments Co. owned 0.09% of FIGS worth $2,190,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. UBS Group AG increased its position in shares of FIGS by 45.2% during the fourth quarter. UBS Group AG now owns 277,151 shares of the company’s stock worth $3,148,000 after acquiring an additional 86,268 shares during the period. Jennison Associates LLC purchased a new stake in shares of FIGS in the fourth quarter valued at approximately $5,717,000. LGT Fund Management Co Ltd. purchased a new stake in shares of FIGS in the first quarter valued at approximately $3,961,000. Hillsdale Investment Management Inc. bought a new position in FIGS in the first quarter worth approximately $7,028,000. Finally, Cookson Peirce & Co. Inc. purchased a new position in FIGS during the 4th quarter worth $1,234,000. Institutional investors own 92.21% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on FIGS shares. Telsey Advisory Group dropped their price target on FIGS from $17.00 to $16.00 and set a “market perform” rating on the stock in a research report on Friday. BTIG Research upped their price objective on shares of FIGS from $20.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday. Zacks Research cut shares of FIGS from a “strong-buy” rating to a “hold” rating in a report on Friday, May 8th. Morgan Stanley raised their target price on shares of FIGS from $8.00 to $15.00 and gave the company an “equal weight” rating in a research report on Monday, April 13th. Finally, Barclays boosted their price target on shares of FIGS from $17.00 to $20.00 and gave the company an “overweight” rating in a report on Friday. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, FIGS presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.71.

FIGS Stock Performance

Shares of NYSE FIGS opened at $14.21 on Friday. The company has a market cap of $2.37 billion, a PE ratio of 43.06 and a beta of 1.03. The business has a 50-day simple moving average of $10.92 and a two-hundred day simple moving average of $12.50. FIGS, Inc. has a fifty-two week low of $6.07 and a fifty-two week high of $17.48.

FIGS (NYSE:FIGS) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. The business had revenue of $159.90 million for the quarter, compared to analyst estimates of $153.15 million. FIGS had a return on equity of 12.65% and a net margin of 8.72%.The business’s revenue was up 28.0% compared to the same quarter last year. On average, sell-side analysts predict that FIGS, Inc. will post 0.27 earnings per share for the current fiscal year.

More FIGS News

Here are the key news stories impacting FIGS this week:

• Positive Sentiment: Quarterly results exceeded expectations. FIGS reported second-quarter revenue of approximately $196.6 million, up 28.8% year over year and ahead of the $186.2 million consensus estimate. Adjusted earnings were reported at $0.15 per share versus analyst expectations of $0.07 and $0.04 in the prior-year quarter. FIGS Releases Second Quarter 2026 Financial Results
• Positive Sentiment: Management raised its full-year outlook. FIGS issued 2026 revenue guidance of approximately $757.3 million, above the $729.1 million Wall Street consensus. The improved outlook signals continued demand for its healthcare apparel and supports expectations for faster growth. Figs shares jump after strong second-quarter results and higher 2026 outlook
• Positive Sentiment: Share repurchases added another support. FIGS increased its buyback authorization, potentially enhancing per-share earnings and signaling management confidence in the company’s valuation and cash-generation outlook. Figs rallies on impressive growth, upbeat outlook, and increased buyback
• Positive Sentiment: BTIG became more bullish. BTIG Research raised its price target from $20 to $22 and reiterated a “buy” rating, reflecting increased confidence in FIGS’ growth trajectory. Benzinga analyst note
• Neutral Sentiment: Analyst opinion remains mixed. Telsey Advisory Group lowered its target from $17 to $16 and kept a “market perform” rating, suggesting the recent rally may have already priced in much of the earnings improvement. The Fly analyst note

FIGS Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.